ArticleTherapeutic advances in medical oncology2024

Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study.

Mashiro Okunaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.